Literature DB >> 9549613

In vitro engineering of human skin-like tissue.

V Zacchi1, C Soranzo, R Cortivo, M Radice, P Brun, G Abatangelo.   

Abstract

Coverage of large, full-thickness burns presents a challenge for the surgeon due to the lack of availability of the patient's own skin. Currently, tissue engineering offers the possibility of performing a suitable therapeutic wound coverage after early burn excision by using cultured keratinocyte sheets supported by a dermal layer. The aim of this study was to develop and characterize a skin substitute composed of both epidermal and dermal elements. For this purpose we grew keratinocytes and fibroblasts separately for 15 days within two different types of biomaterials. Cells then were co-cultured for an additional period of 15 days, after which samples were taken and processed with either classic or immunohistochemical stainings. Results showed that (1) human fibroblasts and keratinocytes can be cultured on hyaluronic acid-derived biomaterials and that (2) the pattern of expression of particular dermal-epidermal molecules is similar to that found in normal skin. The data from this study suggest that our skin equivalent might be useful in the treatment of both burns and chronic wounds.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9549613     DOI: 10.1002/(sici)1097-4636(199805)40:2<187::aid-jbm3>3.0.co;2-h

Source DB:  PubMed          Journal:  J Biomed Mater Res        ISSN: 0021-9304


  16 in total

1.  Gland cell cultures into 3D hyaluronan-based scaffolds.

Authors:  B Zavan; R Cortivo; C Tonello; G Abatangelo
Journal:  J Mater Sci Mater Med       Date:  2003-08       Impact factor: 3.896

2.  Preliminary study of a polycaprolactone membrane utilized as epidermal substrate.

Authors:  Hwei Ling Khor; Kee Woei Ng; Aung Soe Htay; Jan-Thorsten Schantz; Swee Hin Teoh; Dietmar W Hutmacher
Journal:  J Mater Sci Mater Med       Date:  2003-02       Impact factor: 3.896

Review 3.  Inductive tissue engineering with protein and DNA-releasing scaffolds.

Authors:  David M Salvay; Lonnie D Shea
Journal:  Mol Biosyst       Date:  2005-11-25

Review 4.  Repopulation of decellularized whole organ scaffold using stem cells: an emerging technology for the development of neo-organ.

Authors:  Aleem Ahmed Khan; Sandeep Kumar Vishwakarma; Avinash Bardia; J Venkateshwarulu
Journal:  J Artif Organs       Date:  2014-07-17       Impact factor: 1.731

5.  Human dermal microvascular endothelial cells form vascular analogs in cultured skin substitutes after grafting to athymic mice.

Authors:  Dorothy M Supp; Kaila Wilson-Landy; Steven T Boyce
Journal:  FASEB J       Date:  2002-06       Impact factor: 5.191

Review 6.  Hepatic stem cells: A viable approach for the treatment of liver cirrhosis.

Authors:  Md Aejaz Habeeb; Sandeep Kumar Vishwakarma; Avinash Bardia; Aleem Ahmed Khan
Journal:  World J Stem Cells       Date:  2015-06-26       Impact factor: 5.326

7.  Improved in vitro cultivation of endothelial progenitor cells as basis for dermal substitutes with enhanced angiogenic capabilities.

Authors:  Gerrit Grieb; David Simons; Hannah Steinberger; Anna Vollmar; Jürgen Bernhagen; Norbert Pallua
Journal:  Langenbecks Arch Surg       Date:  2011-08-19       Impact factor: 3.445

8.  Differential distribution of elastic tissue in human natural skin and tissue-engineered skin.

Authors:  M Casasco; A Casasco; A Icaro Cornaglia; A Farina; A Calligaro
Journal:  J Mol Histol       Date:  2004-05       Impact factor: 2.611

Review 9.  Naturally-Derived Biomaterials for Tissue Engineering Applications.

Authors:  Matthew Brovold; Joana I Almeida; Iris Pla-Palacín; Pilar Sainz-Arnal; Natalia Sánchez-Romero; Jesus J Rivas; Helen Almeida; Pablo Royo Dachary; Trinidad Serrano-Aulló; Shay Soker; Pedro M Baptista
Journal:  Adv Exp Med Biol       Date:  2018       Impact factor: 2.622

Review 10.  Hyaluronan benzyl ester as a scaffold for tissue engineering.

Authors:  Vincenzo Vindigni; Roberta Cortivo; Laura Iacobellis; Giovanni Abatangelo; Barbara Zavan
Journal:  Int J Mol Sci       Date:  2009-07-03       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.